BridgeMD
New treatment option for Sarcopenia
Official title Effect of Sarcopenia on the Occurrence of Toxicity Related to Anti-cancer Treatments
ClinicalTrials.gov ID: NCT06274268
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn about the effect of sarcopenic status on the occurrence of treatment-related toxicity during the first course of anti-cancer treatment in several types of cancers. The main question it aims to answer is : Is sarcopenia a predictive marker for the occurrence of toxicity in the initial phase of cancer treatment?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients over 18 years old
- Patient with a diagnosis of a histologically proven solid malignant tumor with an indication for systemic treatment during initial treatment.
- CT/PET performed within 45 days before initiation of systemic treatment.
- Patient able to sign informed consent for participation in the study
- Patient affiliated to a social security system
You likely can't join if
- History of cancer in the five years preceding inclusion other than localized skin or cervical cancers.
- Patient with cancer not requiring systemic treatment.
- Pregnant women.
- Patient with a pace maker or defibrillator
- Patient deprived of liberty or benefiting from a legal protection measure
The study team makes the final eligibility decision.
Where it's taking place
- Chambéry, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chambéry, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.